omapatrilat

This page covers all omapatrilat drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Angiotensin-converting enzyme, Neprilysin, Amyloid beta A4 protein.

Targets

Angiotensin-converting enzyme, Neprilysin, Amyloid beta A4 protein

Phase 2 pipeline (1)

• OMAPATRILAT · Cardiovascular
  Omapatrilat works by blocking two enzymes, ACE and neprilysin, to lower blood pressure and improve heart function.

Patent intelligence

• omapatrilat patent landscape — aggregated cliff calendar, attackable patents, originator estates